Vulvar cancer is a rare type of cancer that occurs on the external female genitalia, known as the vulva. It involves the abnormal growth of cells in this area, which can lead to the formation of tumors. While it accounts for only a small percentage of all cancers in women, vulvar cancer can significantly impact a woman's quality of life if not detected and treated early.
The vulva includes several structures, such as the labia majora and minora, clitoris, and the vaginal opening. Vulvar cancer can develop in any of these areas, but it most commonly affects the labia. It is more often seen in older women, particularly those over the age of 60, but it can also occur in younger women, especially those with risk factors such as a history of human papillomavirus (HPV) infection.
The cause of vulvar cancer is not entirely understood, but it is thought to arise from genetic mutations that cause healthy cells to grow uncontrollably. Certain risk factors, such as chronic inflammation, HPV infection, smoking, and a history of vulvar intraepithelial neoplasia (a pre-cancerous condition), can increase the likelihood of developing vulvar cancer.
Symptoms of vulvar cancer may include itching, pain, or the presence of a lump or sore in the vulvar region. In some cases, there may be abnormal bleeding or changes in the color and appearance of the skin.
Early detection and treatment are crucial for the best possible outcomes. The treatment for vulvar cancer typically involves surgery, and in some cases, radiation therapy or chemotherapy may be recommended, depending on the stage and spread of the cancer.
Understanding the symptoms and early warning signs of vulvar cancer is essential for women to seek timely medical attention. Regular gynecological check-ups can help in detecting this cancer at an early stage when it is most treatable.
The exact cause of vulvar cancer is not well understood, but several factors have been identified that increase the risk of developing this disease. These risk factors can be genetic, environmental, or related to pre-existing medical conditions.
The most significant risk factor for vulvar cancer is HPV, a common sexually transmitted infection. Specific types of HPV, particularly types 16 and 18, are strongly associated with vulvar squamous cell carcinoma. Persistent infection with high-risk HPV strains can lead to changes in the cells of the vulva, which may develop into cancer over time. HPV infection is the leading cause of precancerous lesions (known as dysplasia) in the vulva, which, if left untreated, can progress to cancer.
Vulvar cancer is more common in older women, especially those aged 60 to 80 years. As women age, their risk of developing various types of cancers, including vulvar cancer, increases. However, vulvar cancer can also affect younger women, especially those who have a history of HPV infection or other risk factors. The average age of diagnosis is around 70 years old, and the disease is particularly rare in women under 40.
Smoking is one of the most significant preventable risk factors for vulvar cancer. Women who smoke are more likely to have persistent HPV infections, and smoking itself contains carcinogens that can damage the vulvar tissue, increasing the likelihood of cancerous changes. Smokers are also more likely to develop squamous cell carcinoma, the most common type of vulvar cancer.
Chronic irritation or inflammation in the vulvar area can increase the risk of vulvar cancer. Lichen sclerosus, a skin disorder that causes thinning, scarring, and irritation of the vulvar skin, is a known risk factor for vulvar cancer. This condition can cause intense itching, discomfort, and changes in the appearance of the vulva, and over time, it can lead to cancer in some women.
Other conditions that can contribute to chronic irritation include vulvar dystrophy, chronic vulvovaginitis, and poor hygiene. Any ongoing irritation or inflammation should be evaluated by a healthcare provider to prevent the progression of cellular changes that could lead to cancer.
A weakened immune system, due to diseases such as HIV/AIDS or immunosuppressive therapies (e.g., following organ transplantation), can increase the risk of vulvar cancer. The immune system plays a critical role in controlling infections, including HPV. When the immune system is weakened, it may fail to clear the virus, which can allow it to cause persistent infections and lead to cancer.
Although vulvar cancer is not typically hereditary, certain genetic conditions and a family history of cancer can increase a woman's risk. Women with a family history of gynecologic cancers (e.g., cervical cancer, endometrial cancer) or a genetic condition like Lynch syndrome (hereditary non-polyposis colorectal cancer) may be more likely to develop vulvar cancer. Lynch syndrome is associated with several types of cancer, including uterine and colon cancer.
Skin conditions such as vitiligo and melanoma can increase the risk of developing vulvar cancer. Women who have a history of skin cancer or abnormal growths on the skin may need regular screening to ensure any new or unusual changes in the vulva are identified early.
The symptoms of vulvar cancer can vary, depending on the size, location, and stage of the tumor. In its early stages, vulvar cancer may not produce noticeable symptoms, which is why regular gynecological check-ups are essential. As the tumor grows, the following signs and symptoms may appear:
Itching in the vulvar area is one of the most common early symptoms of vulvar cancer. This itching may be persistent and may not respond to over-the-counter treatments. Additionally, some women experience pain or a burning sensation in the vulva, particularly after sexual intercourse.
The development of a lump or growth in the vulvar area is another common symptom. This lump may be small at first, but it can grow in size and may become painful or ulcerated over time.
Women with vulvar cancer may notice abnormal vaginal bleeding, particularly after intercourse. This can include spotting, bleeding between periods, or postmenopausal bleeding (bleeding after menopause), which should be evaluated by a healthcare provider.
Changes in the appearance of the vulva, such as the development of ulcers, sores, or discoloration, may indicate vulvar cancer. The skin on the vulva may appear red, thickened, or scarred. In some cases, the area around the tumor may become swollen or inflamed.
An abnormal vaginal discharge, especially if it is bloody, foul-smelling, or pus-like, may indicate vulvar cancer. This discharge often occurs if the tumor has grown large or is ulcerating.
If the tumor affects the urethra or nearby tissues, women may experience painful urination (dysuria) or difficulty urinating, leading to discomfort and urgency.
In advanced cases, vulvar cancer can spread to the lymph nodes in the groin, leading to swelling in the legs or genital area, a condition known as lymphedema. Swelling may occur as a result of blocked lymphatic drainage, which occurs when cancer cells spread to the lymph nodes.
Diagnosing vulvar cancer involves a combination of physical exams, biopsy, and imaging tests. Since vulvar cancer can sometimes resemble other conditions, a thorough evaluation is essential for an accurate diagnosis.
A pelvic exam is usually the first step in diagnosing vulvar cancer. During this exam, a doctor will visually inspect the vulva for any unusual lumps, sores, or changes in the skin. The doctor may also feel the area for any abnormal masses or enlarged lymph nodes.
A biopsy is necessary to confirm the diagnosis of vulvar cancer. During this procedure, a small sample of tissue from the affected area is removed and examined under a microscope. The biopsy allows the doctor to determine whether the cells are cancerous, and if so, what type of cancer is present.
If an abnormal area is found during the pelvic exam, a colposcopy may be performed. This procedure uses a special magnifying device called a colposcope to examine the vulva more closely. The doctor may take additional tissue samples (biopsies) from areas that look suspicious.
To determine the extent of the cancer and whether it has spread to other parts of the body, imaging tests such as CT scans, MRI, or PET scans may be used. These scans provide detailed images of the pelvic area and can help assess whether the tumor has invaded nearby tissues or lymph nodes.
Blood tests may be conducted to assess general health, check for anemia (which could be caused by bleeding), and evaluate liver and kidney function. However, blood tests are not typically used for diagnosing vulvar cancer but rather to assess the patient’s overall condition.
The treatment for vulvar cancer depends on the type, stage, and location of the tumor, as well as the patient’s overall health. Treatment options may include surgery, radiation therapy, chemotherapy, and targeted therapies.
Wide Local Excision: In cases of early-stage vulvar cancer, wide local excision is the primary treatment. This involves removing the tumor along with a margin of surrounding healthy tissue to ensure all cancer cells are removed.
Vulvectomy: If the tumor is larger or more advanced, a vulvectomy may be necessary. This involves the removal of part or all of the vulva, depending on the size and location of the tumor.
Lymph Node Dissection: If cancer has spread to the lymph nodes, a lymph node dissection may be performed to remove the affected lymph nodes.
Radiation therapy uses high-energy rays to kill cancer cells. It may be used after surgery to eliminate any remaining cancer cells or for tumors that cannot be surgically removed. External beam radiation and brachytherapy (internal radiation) are commonly used for vulvar cancer.
Chemotherapy is often used for advanced vulvar cancer or when the cancer has spread to other parts of the body. Drugs such as cisplatin, carboplatin, and paclitaxel may be used in combination with surgery or radiation therapy to shrink tumors and prevent recurrence.
Immunotherapy is an emerging treatment that helps the body’s immune system recognize and attack cancer cells. While it is not yet a standard treatment for vulvar cancer, it may be an option for advanced or recurrent cancers. Drugs like checkpoint inhibitors (e.g., pembrolizumab) are currently being studied.
While vulvar cancer cannot always be prevented, certain lifestyle changes and medical interventions can reduce the risk of developing the disease.
The HPV vaccine is one of the most effective ways to prevent vulvar cancer. Vaccination helps protect against the high-risk strains of HPV, including types 16 and 18, which are responsible for most vulvar and cervical cancers.
Routine pelvic exams and Pap smears can help detect abnormal cell changes in the vulva or cervix early, improving the chances of successful treatment. Women with a history of HPV infection or vulvar irritation should undergo more frequent screenings.
Since smoking increases the risk of HPV persistence and vulvar cancer, quitting smoking can significantly reduce the likelihood of developing this cancer.
While many women recover well after treatment, there are potential complications associated with vulvar cancer, including:
Recurrence: Vulvar cancer has a higher rate of recurrence, especially in cases where the tumor was not completely removed.
Sexual Dysfunction: Surgery or radiation may cause changes in sexual function, such as pain during intercourse or vaginal dryness.
Lymphedema: Removal of lymph nodes or damage to lymphatic tissue during treatment can cause swelling in the legs or genital area.
Urinary Problems: Tumors near the urethra or surgery affecting the pelvic region can lead to urinary dysfunction
Living with vulvar cancer can be challenging, especially if the disease affects a woman’s sexual health, emotional well-being, and daily activities. Survivors of vulvar cancer may need ongoing medical care to monitor for recurrence and manage any long-term effects from treatment.
Dealing with a cancer diagnosis can cause stress, anxiety, and depression. Counseling and support groups can help women navigate the emotional aspects of their diagnosis and treatment.
Women who undergo surgery or radiation may benefit from physical therapy to address any physical limitations. Additionally, women may need assistance from sexual health specialists to cope with changes in sexual function.
Routine follow-up visits with a gynecologist or oncologist are necessary to monitor for signs of recurrence and manage any ongoing side effects. Women may also need hormonal therapy if their hormonal balance has been disrupted by treatment.
Vulvar cancer is a type of cancer that starts in the outer part of the female genital organs, specifically in the vulva, which is the external part of the female reproductive system. This cancer can develop in the skin or mucous membranes of the vulva and often manifests as lumps, sores, or irritation. It is a rare form of cancer, but its incidence has been rising in recent years.
The exact cause of vulvar cancer is not fully understood, but certain risk factors may increase the likelihood of developing the condition. These include:
Human papillomavirus (HPV) infection, particularly high-risk strains like HPV-16 and HPV-18.
Smoking, which can increase the risk of developing vulvar cancer and other cancers.
Chronic vulvar inflammation or irritation, including conditions like vulvar lichen sclerosus.
Weakened immune system due to conditions like HIV or immunosuppressive therapy.
Older age, as vulvar cancer is more commonly diagnosed in postmenopausal women.
Symptoms of vulvar cancer can vary but often include:
Itching or irritation in the vulvar area
Pain or tenderness in the vulva
A visible lump, growth, or ulcer on the vulva
Abnormal bleeding or discharge, especially after menopause
Changes in the color or appearance of the skin of the vulva
Pain during sexual intercourse
It’s important to note that these symptoms can also be caused by other
non-cancerous conditions, so a medical evaluation is necessary for a proper
diagnosis.
Diagnosis of vulvar cancer typically begins with a physical examination of the vulva. If a suspicious lesion is found, a biopsy (removal of a small sample of tissue) is performed to confirm whether the tissue is cancerous. Additional tests, such as colposcopy (a procedure that allows detailed examination of the vulva), imaging tests (e.g., MRI, CT scans), and pelvic exams may be used to assess the extent of the cancer and check for any spread to nearby lymph nodes or other organs.
Vulvar cancer is staged based on the size of the tumor and whether it has spread to nearby tissues, lymph nodes, or distant organs. The stages range from Stage I (localized to the vulva) to Stage IV (spread to distant organs). The staging system helps determine the prognosis and treatment plan for the patient. Staging is typically done through a combination of physical examination, biopsy, and imaging tests.
Treatment for vulvar cancer depends on the stage of the cancer, its size, and the patient's overall health. Common treatment options include:
Surgery: The most common treatment, which may involve removing part or all of the vulva (vulvectomy). Lymph nodes in the groin area may also be removed if cancer has spread.
Radiation therapy: Used for localized tumors or as an adjuvant therapy after surgery to destroy any remaining cancer cells.
Chemotherapy: Sometimes used for advanced or recurrent vulvar cancer, especially if it has spread to other parts of the body.
Immunotherapy or targeted therapy: These treatments may be used in certain cases, particularly for advanced or recurrent vulvar cancer.
While there is no guaranteed way to prevent vulvar cancer, certain steps can reduce the risk:
Vaccination against HPV: The HPV vaccine can protect against the strains of HPV that cause most cases of vulvar cancer.
Avoid smoking: Quitting smoking can lower the risk of vulvar cancer and many other types of cancer.
Regular gynecological exams: Routine visits to the gynecologist can help detect early signs of vulvar cancer, especially for those at higher risk.
Managing chronic conditions: Treating conditions like vulvar lichen sclerosus or persistent vulvar irritation can help reduce the risk of developing cancer.
The prognosis for vulvar cancer depends on several factors, including the stage of cancer at diagnosis, the type of vulvar cancer, and how well the cancer responds to treatment. Early-stage vulvar cancer has a relatively good prognosis with appropriate treatment, especially if it is localized. However, advanced stages or cancer that has spread to other parts of the body may have a less favorable prognosis. Regular follow-up care is essential to monitor for recurrence.
Potential complications of vulvar cancer and its treatment include:
Lymphedema: Swelling in the legs or genital area caused by removal of lymph nodes or radiation therapy.
Sexual dysfunction: Pain or discomfort during sexual intercourse may result from surgery or radiation therapy.
Recurrence: Vulvar cancer can recur even after successful treatment, especially if the tumor was large or advanced.
Changes in body image: Surgery to remove part of the vulva may lead to emotional and psychological challenges, particularly related to body image and sexuality.
A diagnosis of vulvar cancer can be emotionally challenging, especially since it involves a sensitive area of the body. Patients may experience feelings of anxiety, depression, or a sense of loss of femininity or sexual identity. It is important for patients to seek psychological support through counseling, support groups, or therapy to help manage these emotions. Open communication with healthcare providers, family, and friends is also crucial. Many cancer centers offer specialized support services for patients dealing with the emotional impact of cancer.
Thailand, Malaysia, Singapore, Turkey and India are the most cost effective locations that offer up to almost 80% savings in comparison to the US.
SurgeryPlanet facilitates a plethora of services to the medical treatment traveler also which includes, a hassle free and discounted travel option, a welcome hand at the airport on arrival, travel in an air-conditioned car, round the clock service & support. Your medical evaluation is pre arranged with the least of waiting time. Once your assessment is complete and found medically fit, the procedure is immediately scheduled without a waiting period. Please read through our Services and Testimonials to understand and select your best options.
Major Treatments Abroad: Obesity / Bariatric Surgery | Spine Surgery | Stem Cell therapy | Fertility treatment | Knee replacement in India and Thailand | Heart Surgery | Organ transplant | ../ayurveda Treatment | Heart valve replacement | Hip resurfacing | Hospitals in India and Thailand for Laparoscopic Sterilization| Best hospitals in Asia | JCI & ISO certified Hospitals | Cost effective medical procedures | Healthcare tourism | Complete privacy for affordable cost | Weight loss procedures | Infertility treatment | Board certified physicians | Low cost surgeries
SurgeryPlanet is an Healthcare Facilitator and not a Medical service provider. The information provided in this website is not to be used for diagnosis or treatment of any medical condition or use for any medical purposes. We provide information solely for medical travel facilitation and do not endorse any particular health care provider, hospital, facility, destination or any healthcare service or treatment listed. We are not an agent for, or affiliated to any health care provider, or service listed in our website and is not responsible for health care services provided by them. Choice of hospital or doctor for your healthcare services is your independent decision. Consult your domestic licensed health care provider before seeking the services of any health care provider you learn about from our website.
